DR. GREGORY BERK
Corporate Board Profile
Tech Score:
0
/100
← Back to All Directors
GT Biopharma, Inc.
Filing Date
Source Excerpt
2022-08-17
Dr. Gregory Berk, Includes 50,000 shares underlying vested options.
Data sourced from SEC filings. Last updated: 2025-07-01